Back to top
more

Cognyte Software (CGNT)

(Delayed Data from NSDQ)

$7.25 USD

7.25
257,297

+0.09 (1.26%)

Updated Aug 13, 2024 04:00 PM ET

After-Market: $7.24 -0.01 (-0.14%) 6:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (94 out of 250)

Industry: Internet - Software

Better trading starts here.

Zacks News

Stryker Recalls Sage Unit Products, Guidance Takes a Hit

Added to the voluntary recall, Stryker (SYK) also placed a temporary hold on certain cloth-based products. Share price of Stryker declined massively following the news.

    Patterson Companies (PDCO) Beats on Q1 Earnings, Keeps View

    Patterson Companies' (PDCO) Animal Health business continues to contribute to the bottom line. Stable fiscal 2018 guidance instills investor confidence.

      Civitas Solutions (CIVI) to Acquire Habilitative Services

      Civitas Solutions' (CIVI) proposed acquisition of Habilitative Services will aid the company in capturing the lucrative Minnesota market.

        Accuray (ARAY) Q4 Loss Wider Than Expected, Revenues Beat

        Accuray's (ARAY) new TomoTherapy product platform, also known as Radixact, continues to contribute to the top line. Solid Fiscal 2018 guidance instills investor confidence.

          PerkinElmer Strong on Product Lineup Amid Integration Risks

          PerkinElmer's (PKI) expanding product portfolio helps it gain global market share. However, the company's regular acquisitions pose integration risks.

            Will Cogentix Medical (CGNT) Continue to Surge Higher?

            As of late, it has definitely been a great time to be an investor in Cogentix Medical Inc (CGNT)

              Cogentix (CGNT) Looks Good: Stock Moves Up 5.2% in Session

              Cogentix Medical, Inc. (CGNT) moved big mover last session, as its shares rose over 5% on the day.

                New Strong Sell Stocks for March 29th

                Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                  Why Trump Could Still Be a Threat to Medical Device Stocks

                  The Republican healthcare bill, American Health Care Act (ACHA), which was released earlier this month with the target to repeal the Affordable Care Act (ACA), hasn't found favor with the masses.

                    Owens & Minor (OMI) Reaffirms Tepid 2017 Financial Guidance

                    Owens & Minor Inc. (OMI) outlined its new strategic plan and reaffirmed the financial guidance.

                      TrovaGene (TROV) Reports Wider-than-Expected Loss in Q4

                      TrovaGene Inc. (TROV) reported loss of 31 cents per share in the fourth quarter of 2016, 2 cents wider than the Zacks Consensus Estimate.

                        Cogentix (CGNT) Q4 Earnings and Revenues Miss Estimates

                        Cogentix Medical, Inc. (CGNT) reported adjusted loss of 14 cents per share in the fourth quarter of 2016.

                          Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance

                          Luminex Corporation (LMNX) announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and approximately $271 million for full-year 2016.

                            PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics

                            PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.

                              Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels

                              Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.

                                Air Methods (AIRM): Winter Hits December Passenger Count

                                Air Methods Corporation (AIRM), reported tepid preliminary patient transport and tourism passenger data for the month of Dec 2016.

                                  AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View

                                  AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.

                                    Cerner Extends HNM Partnership with University of Missouri

                                    Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.

                                      Alere Forensic Toxicology Division Gets ABFT Accreditation

                                      Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.

                                        Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay

                                        Luminex Corporation (LMNX) announced that it has received FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization.

                                          Mazor Robotics (MZOR) Receives 21 System Orders in Q4

                                          Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced the receipt of 21 surgical guidance system orders in fourth-quarter 2016.

                                            Cerner Hurt by Low System Sales and Intense Competition

                                            On Jan 3, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN).

                                              Natus Medical Closes GN Otometrics Business Acquisition

                                              Natus Medical Incorporated (BABY) announced the purchase of GN Otometrics from Denmark-based GN Store Nord.

                                                Patterson Companies Hurt by Competition & Integration Risks

                                                On Jan 3, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO), a leading distributor and seller of dental and animal health products.

                                                  Top Ranked Momentum Stocks to Buy for December 12th

                                                  Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 12th: